You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glycogen Storage Disease Type VIII

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biomarker for Glycogen Storage Diseases (BioGlycogen)

Active, not recruiting
  • Fructose Metabolism, Inborn Errors
  • +9 more
    • Rostock, Germany
    • +3 more
    May 12, 2021

    Biospecimen in Pediatric Patients and Adult Guardians Diagnosed

    Recruiting
    • Glycogen Storage Disease Type IB
    • Specimen Donation
    • Woburn, Massachusetts
      Sanguine BioSciences, Inc.
    Jun 22, 2023

    Pompe Disease, Muscle Loss, Obesity Trial (Multi-ingredient supplement (PDT-MIS), Placebo (PLA))

    Not yet recruiting
    • Pompe Disease
    • +7 more
    • Multi-ingredient supplement (PDT-MIS)
    • Placebo (PLA)
    • (no location specified)
    Nov 8, 2023

    Glycogen Storage Disease VI, GLYCOGEN STORAGE DISEASE IXa1, GLYCOGEN STORAGE DISEASE IXa2 Trial in Durham (No intervention)

    Recruiting
    • Glycogen Storage Disease VI
    • +4 more
    • No intervention
    • Durham, North Carolina
      Duke University
    Jul 27, 2022

    Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage

    Recruiting
    • Glycogen Storage Disease
    • +2 more
    • No intervention
    • Copenhagen, Copenhange, Denmark
      Neuromuscular Research Unit, 8077
    Oct 26, 2022

    Pompe Disease -Non-invasive Magnetic Resonance Exploratory Pilot

    Not yet recruiting
    • Pompe Disease
    • McArdle Disease
    • Siemens Magnetom 7T Plus
    • Vienna, Austria
      Medical University of Vienna
    Jul 5, 2023

    Hypoglycemia in Glycogen Storage Disease Type III

    Recruiting
    • Glycogen Storage Disease Type III
    • No Intervention
    • Philadelphia, Pennsylvania
    • +1 more
    Jul 22, 2022

    Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Acid Maltase Deficiency Disease Trial in Gainesville, Decatur, Detroit

    Completed
    Has Results
    • Pompe Disease
    • +2 more
    • alglucosidase alfa
    • Gainesville, Florida
    • +2 more
    Jul 29, 2022

    Glycogen Storage Disease Type IV, Adult Polyglucosan Body Disease Trial in Durham (No intervention)

    Recruiting
    • Glycogen Storage Disease Type IV
    • Adult Polyglucosan Body Disease
    • No intervention
    • Durham, North Carolina
      Duke University Medical Center
    May 20, 2022

    Glycogen Storage Disease Type IB Trial in Shanghai (Empagliflozin)

    Recruiting
    • Glycogen Storage Disease Type IB
    • Shanghai, Shanghai, China
      Xinhua Hospital, Shanghai Jiao Tong University School of Medicin
    Jul 17, 2023

    Adeno-Associated Virus Antibody Study in Subjects OTC

    Recruiting
    • Ornithine Transcarbamylase Deficiency
    • +2 more
      • Akron, Ohio
      • +2 more
      Jul 22, 2022

      Glycogen Storage Disease Type III Trial in Worldwide (biological, other, drug)

      Recruiting
      • Glycogen Storage Disease Type III
      • UX053
      • +4 more
      • Orange, California
      • +9 more
      Jul 22, 2022

      Glycogen Storage Disease Type IA Trial in Groningen ([6,6-2H2]glucose)

      Completed
      • Glycogen Storage Disease Type IA
      • [6,6-2H2]glucose
      • Groningen, Netherlands
        University of Groningen, UMC Groningen
      Feb 10, 2022

      Glycogen Storage Disease Type IA Trial in Worldwide (genetic, other, drug)

      Recruiting
      • Glycogen Storage Disease Type IA
      • DTX401
      • +3 more
      • Orange, California
      • +16 more
      Jan 13, 2023

      Glycogen Storage Disease Trial in United States (mRNA-3745)

      Recruiting
      • Glycogen Storage Disease
      • Farmington, Connecticut
      • +4 more
      Jun 10, 2022

      GSD1 Trial in Worldwide (DTX401)

      Completed
      Has Results
      • GSD1
      • DTX401
      • steroid regimen
      • Farmington, Connecticut
      • +5 more
      Oct 25, 2022

      Pompe Disease (Late-onset) Trial (No Intervention)

      Not yet recruiting
      • Pompe Disease (Late-onset)
      • No Intervention
      • (no location specified)
      Nov 21, 2023

      Glycogen Storage Disease Type II, Pompe Disease (Late-onset) Trial in Milan (Inspiratory Muscle Training (IMT), Inspiratory

      Recruiting
      • Glycogen Storage Disease Type II
      • Pompe Disease (Late-onset)
      • Inspiratory Muscle Training (IMT)
      • Inspiratory Muscle Training (IMT) + Air Stacking
      • Milan, Italy
        IRCCS S. Maria Nascente - Fondazione Don Carlo Gnocchi
      Jul 11, 2023

      Glycogen Storage Disease Type I Trial in Durham (Triheptanoin)

      Completed
      • Glycogen Storage Disease Type I
      • Durham, North Carolina
        Duke University Medical Center
      Dec 14, 2021

      Glycogen Storage Disease Type II Infantile Onset Trial in Gainesville (Cipaglucosidase alfa (ATB200), Miglustat (AT2221))

      Recruiting
      • Glycogen Storage Disease Type II Infantile Onset
      • Gainesville, Florida
        University of Florida Clinical Research Center
      Jan 18, 2023

      Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)

      Recruiting
      • Mucopolysaccharidosis I
      • +7 more
      • There is no intervention
      • San Francisco, California
        University of California San Francisco
      Nov 9, 2022

      Natural History of Pompe Disease

      Recruiting
      • Glycogen Storage Disease Type II, Adult
        • Garches, Hauts-de-Seine, France
          Hôpital Raymond Poincaré
        Apr 20, 2022

        Glycogen Storage Disease Type II Trial in Worldwide (Alglucosidase alfa GZ419829)

        Recruiting
        • Glycogen Storage Disease Type II
        • Alglucosidase alfa GZ419829
        • Leuven, Belgium
        • +8 more
        Jan 17, 2023

        Pompe Disease, Pompe Disease (Late-onset), Pompe's Disease Juvenile Onset Trial in Erlangen (Multispectral Optoacoustic

        Recruiting
        • Pompe Disease
        • +3 more
        • Multispectral Optoacoustic Tomography
        • Erlangen, Bavaria, Germany
          University Hospital Erlangen
        Jun 2, 2022

        Pompe Disease Trial in New York, Fairfax (biological, drug, other)

        Not yet recruiting
        • Pompe Disease
        • Cipaglucosidase alfa
        • +3 more
        • New York, New York
        • +1 more
        Nov 2, 2023